Stock CRNX CRINETICS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Crinetics Pharmaceuticals, Inc.

Equities

CRNX

US22663K1079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
42.12 USD -0.40% Intraday chart for Crinetics Pharmaceuticals, Inc. -1.98% +18.38%
Apr. 17 Crinetics Pharmaceuticals Insider Sold Shares Worth $639,256, According to a Recent SEC Filing MT
Mar. 26 Crinetics Pharmaceuticals Insider Sold Shares Worth $1,433,675, According to a Recent SEC Filing MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Global markets live: Apple, AbbVie, Comcast, FMC Accenture...Global markets live: Apple, AbbVie, Comcast, FMC Accenture... December 19, 2023 at 11:30 am EST
Investors got more clues that rate cuts are imminentInvestors got more clues that rate cuts are imminent December 19, 2023 at 09:30 am EST
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRNX Stock
  4. News Crinetics Pharmaceuticals, Inc.
  5. MarketScreener Editorial Features